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Leakage after oesophageal anastomosis or perforation remains a challenge for the surgeon. Traditional management has
been operative repair or intensive conservative management. Both treatments are associated with prolonged hospitalisation
and high morbidity and mortality rates. Self-expanding metallic stents have played an important role in the palliation of
malignant oesophageal strictures and the treatment of tracheoesophageal ﬁstulae. However, self-expanding metal stents in benign
oesophageal disease are associated with complications such as bleeding, food bolus impaction, stent migration, and diﬃculty in
retrieval. The Polyﬂex stent is the only commercially available self-expanding plastic stent which has been used in the management
of malignant oesophageal strictures with good results. This review will consider the literature concerning the use of self-expanding
plastic stents in the treatment of oesophageal anastomotic leakage and spontaneous perforations of the oesophagus.
1.Introduction
Stents have played an important role over the last few years
for the palliation of malignant oesophageal strictures and
the treatment of tracheoesophageal ﬁstulae [1]. There are
several types of commercial stents available, but they can
largely be separated into two groups: metal or plastic stents.
Self-expanding metal stents (SEMSs) are made of stainless
steel (Z stent, Cook), nitinol (Ultraﬂex, Boston Scientiﬁc), or
elgiloy (Wallstent, Boston Scientiﬁc) and may be uncovered,
partially covered, or fully covered. Uncovered or partially
coveredstents(e.g.,Ultraﬂex)allowﬁxingtotheoesophageal
lumen, but they have a tendency to become blocked due
to tumour overgrowth. Fully covered metal stents (e.g.,
Niti-S) are beneﬁcial in controlling leakage and can be
easily retrieved, but they are prone to migration. There is
currentlyonlyonecommerciallyavailableplasticstentonthe
market—the Polyﬂex stent produced by Boston Scientiﬁc.
These stents have been successfully used in the management
of benign and malignant oesophageal strictures [2].
SEMS replaced rigid metal stents in the 1990s and have
been successfully used for the management of tracheoe-
sophageal ﬁstulae and malignant strictures [3, 4]. They are
relativelyeasytodeploy,haveahighsuccessrate,andprovide
rapid symptom relief. There are also reports in the literature
regarding the use of SEMS for the successful treatment of
benignoesophagealdiseaseincludingperforations.However,
these partially covered or uncovered SEMSs were associated
with relatively high complication rates (26–52%) including
bleeding, perforation, stent migration, pain, ingrowth, and
food bolus impaction [5]. As a result, many centres would
not advocate the use of uncovered or partially covered stents
in benign disease [6].
The Polyﬂex stent is a self-expanding plastic stent (SEPS)
of polyester braid completely covered in silicone membrane.
The proximal end is ﬂared to prevent dislocation and
ensure reliable occlusion with radioopaque markers at both
ends and in the middle to facilitate accurate placement.
The Polyﬂex stent overcomes some of the disadvantages
associated with SEMS allowing easier retrieval and possibly
less migration than uncovered or partially covered SEMS
[7]. The soft material ensures well-balanced radial force and
adapts to the oesophageal wall allowing reliable leak occlu-
sion while the complete silicone covering prevents ingrowth
and overgrowth of granulation tissue making it easier to
repositionandretrieve.Thiscanbedoneendoscopicallywith2 Diagnostic and Therapeutic Endoscopy
specially designed forceps. The Polyﬂex stent is available in
varioussizeswithdiametersof16,18,and21mmandlengths
of 9, 12, or 15cm. The exact size of stent will depend on
the site and the size of the leakage, the operator’s preference
and the size of the oesophagus. A study assessing stent size
and migration rates using SEMS in patients with malignant
dysphagia suggests that a larger-diameter stent is associated
with reduced migration rates. However, as yet there is no
published evidence that this applies to SEPS [8].
Recently, there has been a move towards managing
oesophageal leakage either secondary to perforations (spon-
taneous or iatrogenic) or from oesophageal anastomoses
(after oesophagectomy or total gastrectomy), in a non-
operative way with the use of nutritional support, pleu-
ral/mediastinal drainage, and broad spectrum antibiotics
in a critical care setting. There are now reports in the
literatureusingthePolyﬂexstent,avoidingthemorbidityand
mortality of further surgical procedures.
This paper will consider the literature concerning the use
of self-expanding plastic stents in the treatment of oesophag-
eal anastomotic leakage and spontaneous perforations of the
oesophagus.
2.LiteratureSearch
A literature search was performed using PubMed, Medline,
and Embase databases searching for the English litera-
ture (reviews, original articles and case reports) available
since 1975. The search was performed with mesh terms
“oesophageal anastomotic leak”, “Polyﬂex stents”, “SEMS”,
“SEPS” and “spontaneous oesophageal rupture”. All related
articles were examined.
3. Anastomotic Leaks
Oesophagectomy and total gastrectomy remain challenging
operations that are associated with considerable morbidity
and mortality even in specialised centres. The National
Oesophagogastric Cancer Audit of England and Wales pub-
lished anastomotic leak rates of 8.3% after oesophagectomy
and 5.9% after gastrectomy [9]. Despite improvements in
anastomotic technique and perioperative care, intrathoracic
anastomotic leakage is associated with contamination, large
abscesses, and ﬁstulas into pleural cavities which are often
diﬃcult to control. The constant leakage of gastric juices
and saliva into the pleural and mediastinal cavities make
this a life-threatening condition responsible for 30–40% of
postoperative deaths [10–12].
The management of oesophagogastric and oesophago-
jejunal anastomotic leakage remains controversial. Some
authors recommend aggressive surgical treatment, whereas
others advocate a conservative approach of perianastomotic
drainage, parenteral nutritional support, nasogastric decom-
pression, and intravenous broad-spectrumantibiotics. These
patients should all be managed in an appropriate critical
care environment [11, 12]. Patients in both groups have
considerablemortality ratesand prolongedICU and hospital
stays.
The application of ﬁbrin glue and endoclips have been
successfully used in the management of very small oeso-
phageal leaks [13, 14]. An endoscopic treatment would seem
an attractive option, and the Polyﬂex stent oﬀers promising
results.
Table 1 summarises the relevant case series with the indi-
cations, complications, and outcomes [7, 15–19]. These data
suggest that plastic stents seem to be straightforward to
place with an almost 100% immediate placement success. In
our personal experience, the loading device and subsequent
delivery of the stent can be challenging and associated with
a signiﬁcant learning curve. A further diﬃculty is that the
diameter of the stent delivery device is 12–14mm, and in
some situations, dilation prior to stent insertion may be
required. However, this is more likely to be encountered
in cases of stricturing disease rather than leakage. The
immediate leak occlusion rates varied from 60–100% with
more than 90% healing rates. Leak occlusion was assessed
by water soluble contrast studies and endoscopic assessment.
Stents were removed at various points, but the majority
were removed between 14 and 28 days with healing assessed
clinically by the absence of sepsis and reduction in chest
drain eﬄuent, endoscopically and radiologically by contrast
studies. While the literature is limited regarding optimal
timing of stent placement, the majority of series-favoured
stent placement immediately after the diagnosis was made in
ordertominimiseorcontrolcontaminationintomediastinal
or pleural cavities [15]. However, even delayed placement
resulted in closure of the anastomotic leak. Patients treated
with Polyﬂex stent had earlier oral intake (mean 11 days
versus 23 days), less extensive ICU stay (mean 25 days versus
47 days), and a shorter overall hospital stay (mean 35 days
versus 57 days). The inhospital mortality rate across the
series varied from 0–20% which was lower than that in the
conservatively treated arm [16, 18].
4. Spontaneous Oesophageal Perforation
Spontaneous oesophageal perforation is a life-threatening
condition that traditionally requires surgical repair. Manage-
ment of this condition can be divided into two categories—
conservative and operative. Due to the uncommon nature of
this condition, the literature is based mainly on small case
series and individual reports.
Operative intervention still seems to be the best treat-
ment for cases with an early diagnosis. Reported mortality
rates vary from 0% if treatment started within 24 hours to
30% if delayed [20].
Conservative treatment consists of broad-spectrum
antibiotic therapy, nutritional support, and/or percutaneous
drainage of collections. Ivey and colleagues suggest conser-
vative therapy is only appropriate if the following criteria
are met—the perforation is ﬁve days old, there are no
signs of severe sepsis, there is a wide mouth cavity on
contrast studies draining freely back into the oesophagus,
and the pleural space is not contaminated [21]. A recent
reviewsuggeststhatconservativemeasuresseemfeasiblewithDiagnostic and Therapeutic Endoscopy 3
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e4 Diagnostic and Therapeutic Endoscopy
survival rates of 60–70% in selected cases if patients are
diagnosed promptly and are not septic, but conversion to
surgery remains necessary in those who fail to progress [22].
Griﬃn et al. published their experience of the man-
agement of spontaneous oesophageal perforation and do
not advocate the use of stents in this situation. They feel
the stent may prevent adequate drainage of sepsis, delay
healing, and be subject to migration as there is no stricture
to keep it in place. They would recommend intensive
nonoperative management in carefully selected patients with
a low threshold for surgery [20].
There are only three case reports in the literature
describing the successful treatment of spontaneous rupture
with temporary placement of a SEPS (Polyﬂex stent). One
was placed in the immediate period (within 24hrs), another
in a delayed (three weeks) setting after a trial of conservative
managementwithchestdrainage,antibiotics,andﬁbringlue,
and the ﬁnal case placed ten days after initial treatment.
All patients survived, and immediate postprocedure studies
showed no extravasation of contrast [15, 23, 24]. Full oral
intake was resumed in all patients within one week, and all
patients discharged between 7 and 21 days postprocedure.
Elective stent removal was carried out between 5 and 10
weeks. In two cases, the stent had migrated into the stomach.
All patients were well at 6 months with no diﬃculty in
swallowing.
5. Discussion
The Polyﬂex self-expanding plastic stent appears to be a
feasible alternative option in the treatment of patients with
anastomotic leaks following oesophagectomy, total gastrec-
tomy, and spontaneous oesophageal perforation. Surgery
for both conditions is associated with signiﬁcant morbidity
and mortality even in specialised centres, but the use of
endoscopic therapies may improve outcomes in selected
patients.
The Polyﬂex stent itself is relatively simple to place endo-
scopically, comes in a range of sizes, is eﬀective, and can be
easily repositioned and removed. Patients with intrathoracic
anastomotic leakage and spontaneous oesophageal perfora-
tion are often critically ill, and the option of endoscopic
intervention without the stresses associated with major
surgery must be an attractive option. While the literature
surrounding the use of Polyﬂex stents is still in its infancy,
the results are interesting and encouraging.
The general advantage of the Polyﬂex stent is immediate
occlusion of the anastomotic leakage or perforation at one
endoscopic session that allows earlier oral/enteral feeding.
PatientstreatedwiththePolyﬂexstenthadearlieroralintake,
less extensive ICU course, and shorter hospital stays [16].
The Polyﬂex stent allows nonoperative treatment of patients
with anastomotic leak who historically would have required
surgical intervention [25]. The plastic stent overcomes the
diﬃculties of the well-recognised complications associated
with partially covered SEMS—perforation, bleeding, and
diﬃculty in retrieval—because their uncovered ends quickly
become embedded in the oesophageal wall. In some patients,
argon plasma coagulation is required to remove the stent,
and post procedure stenoses from extensive mucosal damage
are documented [26–28].
The main disadvantage throughout the literature is the
tendency of the Polyﬂex stent to migrate with reported
rates between 5 and 23% (see Table 1). Its complete silicone
coating allows easy retrieval, but it is this property that
makes it prone to migration as there is minimal granulation
reaction. Some groups have tried to keep the stent position
using endoclips at the proximal and distal ends with limited
success. Dai et al. reported reintervention rates of 80% (4
of 5 patients with stent migration), although these were
successfully treated with repeat endoscopic intervention,
either by repositioning the stent with forceps or clips,
or to be restenting [7]. The other concern suggested by
Griﬃn is that stents may prevent adequate drainage in cases
with spontaneous oesophageal perforation. Spontaneous
perforation of the oesophagus is associated with signiﬁcant
contaminationofthepleuralandmediastinalcavitiesandthe
presence of a covered stent, although controlling the leakage
may result in inadequate drainage [20]. They recommend
intensive nonoperative management with a low threshold for
surgery.
Most authors suggest carrying out stent placement
immediately after the diagnosis is made to limit further
contamination. Although there is no evidence from SEPS
about the timing of stent placement and healing, there is
indirect evidence from endoscopic clipping in the manage-
ment of oesophageal perforations. Qadeer et al. describe 17
patients in whom endoscopic clipping was used to close
oesophageal perforations (mainly iatrogenic) and showed
that the median healing time after clipping was 18 days [14].
Most of the acute perforations from therapeutic endoscopy
closed by 5 days, but in older perforations initially treated
conservatively before undergoing endoscopic clipping, there
was a delay in healing time. For every 10-day increase in
the duration of the perforation, healing time increased by 7
days.Allpatientsshouldbemanagedinacriticalcaresetting,
withbroad-spectrumantibiotictherapy,nutritionalsupport,
and eﬀective drainage of the perianastomotic area and
mediastinal/pleural cavities to avoid septic complications.
This may be achieved from chest drainage tubes if they are
still in place, or the insertion of CT-guided percutaneous
catheters. Some authors feel a dehiscence of more than 70%
of the anastomosis with an ischaemic anastomotic line tends
not suitable for endoscopic treatment, and reoperation is
required [17, 18]. If clinical markers or physiological param-
eters are not improving, reoperation should be considered.
There is discrepancy in the literature concerning the retrieval
of the Polyﬂex stent once the leak has healed. Some groups
remove the stent at 14 days and assess healing and viability
of the oesophagus [18] ,w h i l es o m eg r o u p sf a v o u rs t e n t
removal only when it becomes troublesome [17]. Further
studies are required before ﬁnal conclusions are drawn. The
published literature commenting on stent size in patients
with oesophageal leakage is poor, although common sense
would dictate that the larger stent is required in this situation
due to the lack of oesophageal stricture.
The main principles from the literature suggest that
all patients regardless of the underlying pathology shouldDiagnostic and Therapeutic Endoscopy 5
be managed in a critical care setting, with broad spec-
trum antibiotic therapy, nutritional support, and adequate
drainage of the pleural and mediastinal cavities to avoid
septic complications. Appropriate drainage of cavities is
essential, particularly in the case of spontaneous oesophageal
perforation where food debris can lie in the pleural or
mediastinal cavities resulting in signiﬁcant septic compli-
cations. These cavities must be drained by well-placed
surgical or radiologically guided drains, but in some cases,
a minithoracotomy (either surgical or laparoscopic assisted)
and washout may be required to control contamination.
The management of these complex patients should involve
a multidisciplinary team comprising a surgeon, a competent
endoscopist, andaninterventionalradiologist. Nonoperative
management with stents should be instituted as quickly as
possible to minimise pleural and mediastinal contamination.
Surgicalreexploration,however,shouldalwaysbeconsidered
inpatientswhodonotclinicallyimprovewiththistreatment.
The literature suggests that plastic stents may be of use in
patients with leakage from an oesophageal anastomosis but
perhaps not for spontaneous perforation. If the dehiscence is
more than 70% and ischaemia/tension present, most groups
would be advocated reoperation, with the stents being used
in smaller leaks and patients who may not survive further
surgery [18].
Two fully covered retrievable SEMS, the Niti-S (Tae-
Woong) and the covered Wallﬂex (Boston Scientiﬁc), have
recently been FDA approved for the use in malignant
oesophageal strictures although there is no data to support
their routine use in benign disease including perforations
at present [2]. A study assessing the eﬃcacy of the alveolus
oesophageal stent system (a nitonol stent fully covered
internally allowing the outer portion to adhere to the
oesophageal lumen) has be shown to successfully occlude the
leakorﬁstulain4of7(57%)patients[29].ThePolyﬂexstent
andnewerfullycoveredmetalstentsareattractiveoptionsfor
the use in controlling oesophageal leakage and may be more
cost eﬀective than currently used partially covered SEMS.
However, further research in this area is required to assess
the long-term clinical and ﬁnancial implications.
A further area of interest is the use of biodegradable
stents in the management of benign oesophageal conditions
asthiswouldnegatetheneedforstentremoval[2].Although
these are exciting prospects, long-term data from good-
quality studies needs to be collated before these stents are
widely adopted into clinical practice. However, while these
stents may have a role in the management of benign stricture
disease, their use in oesophageal perforation seems unlikely
as they are not covered and would not control leakage.
6. Conclusion
The literature search has shown that data is scarce, and
the paucity of large case series or trials has resulted in a
lack of clinical standards or guidelines to aid management
of patients with oesophageal leakage. However, the limited
results are promising, and endoscopic therapy with a self-
expanding stent should be borne in mind when treating
patients with oesophageal leakage.
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